Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 10 Results

Title
Intervention Indication Therapeutic Area Year Actions
Atogepant for prevention of migraine Atogepant (AGN-241689; MK-8031) Migraine Neurology 2022 View  |  Download
Botulinum toxin type A for preventing episodic migraine Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Migraine Neurology 2023 View  |  Download
Eptinezumab for prevention of Migraine Eptinezumab (ALD403) Migraine Neurology 2020 View  |  Download
Fremanezumab for chronic and episodic migraine Fremanezumab (TEV-48125; Ajovy) Migraine Neurology 2017 View  |  Download
Galcanezumab for preventing migraine in children Galcanezumab (Emgality; LY-2951742) Migraine Neurology 2023 View  |  Download
Galcanezumab for the prophylaxis of episodic and chronic migraine Galcanezumab (Emgality; LY-2951742) Migraine Neurology 2017 View  |  Download
Lasmiditan for acute treatment of migraine Lasmiditan (COL-144; LY573144) Migraine Neurology 2020 View  |  Download
Rimegepant for the treatment of Acute Migraine Rimegepant (Zydis; BHV3000; Nurtec) Migraine Neurology 2018 View  |  Download
STS101 for the acute treatment of migraine STS-101 (TO-2070, dihydroergotamine) Migraine Neurology 2022 View  |  Download
Zavegepant for treating acute migraine Zavegepant (BHV-3500) Migraine Neurology 2024 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications